Autopsy report · NCT03563274

QuiremSpheres Observational Study

“did not meet planned recruitment expectations with a slow recruitment rate”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Terumo Europe N.V.

Sponsor type

Industry

Conditions

Liver, Cancer of, Non-Resectable

Interventions

Selective Internal Radiation Therapy with QuiremSpheres®

Participants

20

Sites

2

Countries

Germany, Netherlands

Trials that died the same way

• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (82% match in meaning)
• Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
  “Slower than expected recruitment rate” (82% match in meaning)
• Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients
  “The recruitment rate was much slower than expected.” (81% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (81% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.